A Cohort Study of Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy by Applying Wearable Electrocardiogram
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Incidence
研究概览
简要总结
This prospective cohort study is to investigate the incidence of atrial fibrillation after chemotherapy by aplying wearable ECG recoder and the risk factors on patients with newly diagonsed lymphoma
详细描述
This prospective, single-centre, observational cohort study is disigned to enroll 100 newly diagnosed lymphoma patients who met the inclusion and exclusion criteria to monitor the onset of atrial fibrillation and other arrhythmias during chemotherapy by using wearable ECG recorder, and to evaluate the incidence of atrial fibrillation and related risk factors.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least 18 years old;
- •Concurrent chemotherapy on patients with new-onset lymphoma: chemotherapy regimens containing anthracyclines;
- •The subject voluntarily signed the informed consent.
排除标准
- •With heart failure, acute stroke or acute coronary syndrome within 3 months before admission
- •With Atrial fibrillation on admission
- •Patient after pacemaker surgery
- •With mental illness or mentally disabled
- •Patients that the investigator considers as unsuitable for this test
结局指标
主要结局
Incidence
时间窗: 1 year after the first course of chemotherapy
Incidence of atrial fibrillation after chemotherapy
次要结局
未报告次要终点
研究者
Yun Dai Chen
professor
Chinese PLA General Hospital
